Drugs / Type 2 collagen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07323745 | May → Dec 2026 expected | osteoarthritis, knee | Universiti Sains Malaysia | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT04267432 Comparator | Mar 2018 → Jun 2019 | osteoarthritis | TCI Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Type 2 collagen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07323745 ↗ |
| Known as | UC-II | “This study's intervention is undenatured type II collagen (UC-II) oral tablets” NCT07323745 ↗ |
| Modality | Protein / enzyme biologic | “This study's intervention is undenatured type II collagen (UC-II) oral tablets” NCT07323745 ↗ |
| Route | Oral | “undenatured type II collagen (UC-II) oral tablets” NCT07323745 ↗ |